Literature DB >> 11160940

Identification of sample-specific sequences in mammalian cDNA and genomic DNA by the novel ligation-mediated subtraction (Limes).

T E Hansen-Hagge1, U Trefzer, A S zu Reventlow, K Kaltoft, W Sterry.   

Abstract

The representational difference analysis (RDA) and other subtraction techniques are used to enrich sample-specific sequences by elimination of ubiquitous sequences existing in both the sample of interest (tester) and the subtraction partner (driver). While applying the RDA to genomic DNA of cutaneous lymphoma cells in order to identify tumor relevant alterations, we predominantly isolated repetitive sequences and artificial repeat-mediated fusion products of otherwise independent PCR fragments (PCR hybrids). Since these products severely interfered with the isolation of tester-specific fragments, we developed a considerably more robust and efficient approach, termed ligation-mediated subtraction (Limes). In first applications of Limes, genomic sequences and/or transcripts of genes involved in the regulation of transcription, such as transforming growth factor beta stimulated clone 22 related gene (TSC-22R), cell death and cytokine production (caspase-1) or antigen presentation (HLA class II sequences), were found to be completely absent in a cutaneous lymphoma line. On the assumption that mutations in tumor-relevant genes can affect their transcription pattern, a protocol was developed and successfully applied that allows the identification of such sequences. Due to these results, Limes may substitute/supplement other subtraction/comparison techniques such as RDA or DNA microarray techniques in a variety of different research fields.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160940      PMCID: PMC29627          DOI: 10.1093/nar/29.4.e20

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  22 in total

1.  Isolation of binary species-specific PCR-based markers and their value for diagnostic applications.

Authors:  A Nekrutenko; K D Makova; R J Baker
Journal:  Gene       Date:  2000-05-16       Impact factor: 3.688

2.  Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium.

Authors: 
Journal:  Nature       Date:  1999-10-28       Impact factor: 49.962

3.  Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.

Authors:  P Liang; A B Pardee
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

4.  A T-cell epitope determined with random peptide libraries and combinatorial peptide chemistry stimulates T cells specific for cutaneous T-cell lymphoma.

Authors:  T Linnemann; K H Wiesmüller; S Gellrich; K Kaltoft; W Sterry; P Walden
Journal:  Ann Oncol       Date:  2000       Impact factor: 32.976

5.  Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides.

Authors:  K Kaltoft; S Bisballe; T Dyrberg; E Boel; P B Rasmussen; K Thestrup-Pedersen
Journal:  In Vitro Cell Dev Biol       Date:  1992-03

6.  Isolation of cDNA clones encoding T cell-specific membrane-associated proteins.

Authors:  S M Hedrick; D I Cohen; E A Nielsen; M M Davis
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

7.  Removal of repeated sequences from hybridisation probes.

Authors:  P G Sealey; P A Whittaker; E M Southern
Journal:  Nucleic Acids Res       Date:  1985-03-25       Impact factor: 16.971

8.  The prodomain of caspase-1 enhances Fas-mediated apoptosis through facilitation of caspase-8 activation.

Authors:  T Tatsuta; A Shiraishi; J D Mountz
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

9.  A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes.

Authors:  B Drénou; V Blancheteau; D H Burgess; R Fauchet; D J Charron; N A Mooney
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

10.  Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients.

Authors:  S Yokota; T E Hansen-Hagge; W D Ludwig; A Reiter; A Raghavachar; E Kleihauer; C R Bartram
Journal:  Blood       Date:  1991-01-15       Impact factor: 22.113

View more
  1 in total

1.  Hybridization-based antibody cDNA recovery for the production of recombinant antibodies identified by repertoire sequencing.

Authors:  Javier Valdés-Alemán; Juan Téllez-Sosa; Marbella Ovilla-Muñoz; Elizabeth Godoy-Lozano; Daniel Velázquez-Ramírez; Humberto Valdovinos-Torres; Rosa E Gómez-Barreto; Jesús Martinez-Barnetche
Journal:  MAbs       Date:  2013-12-11       Impact factor: 5.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.